SFA
RPRX icon

Sequoia Financial Advisors’s Royalty Pharma RPRX Stock Holding History

Sequoia Financial Advisors’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$982K Buy
17,513
+1,843
+12% +$95.9K ﹤0.01% 957
2026
Q1 		$752K Buy
15,670
+3,981
+34% +$174K ﹤0.01% 1029
2025
Q4 		$452K Buy
11,689
+1,859
+19% +$70.9K ﹤0.01% 1332
2025
Q3 		$347K Buy
9,830
+3,360
+52% +$122K ﹤0.01% 1320
2025
Q2 		$233K Buy
+6,470
New +$214K ﹤0.01% 1405

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sequoia Financial Advisors's RPRX Position: Q2 2026 in Review

Sequoia Financial Advisors increased its Royalty Pharma (RPRX) stake by 12% in Q2 2026, buying an estimated $95.9K and bringing the position to 17,513 shares worth $982K. The position accounts for ﹤0.01% of the portfolio, ranked #957.

Sequoia Financial Advisors first reported a position in RPRX in Q2 2025 and has held it in 5 quarters since. 641 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Sequoia Financial Advisors held 17,513 shares of Royalty Pharma worth $982K as of Q2 2026.
  • Sequoia Financial Advisors bought 1,843 Royalty Pharma shares in Q2 2026, an estimated $95.9K.
  • Royalty Pharma made up ﹤0.01% of Sequoia Financial Advisors's portfolio in Q2 2026, its #957 holding.
  • Sequoia Financial Advisors first reported a position in Royalty Pharma in Q2 2025 and has held it in 5 quarters since.
  • 641 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Sequoia Financial Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.